<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05060000_1</Organism_ID>
  <Organism>HIV-1</Organism>
  <Organism_Latin>Human immunodeficiency virus type 1</Organism_Latin>
  <UniProt_ID>G3G0I2</UniProt_ID>
  <Seq_Length>288</Seq_Length>
  <Molecule_Weight>32222</Molecule_Weight>
  <Catalytic_Mechanism>Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).</Catalytic_Mechanism>
  <Pfam_ID>PF00552:IN_DBD_C@@PF02022:Integrase_Zn@@PF00665:rve</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>118</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Integrase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks.</Detail>
      <Keyword>Endonuclease activity</Keyword>
      <Ontology_ID>GO:0004519</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular function by which a gene product interacts selectively with DNA (deoxyribonucleic acid).</Detail>
      <Keyword>DNA binding</Keyword>
      <Ontology_ID>GO:0003677</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes RNA-template-directed extension of the 3'- end of a DNA strand by one deoxynucleotide at a time.</Detail>
      <Keyword>RNA-directed DNA polymerase activity</Keyword>
      <Ontology_ID>GO:0003964</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a nucleotidyl group to a reactant.</Detail>
      <Keyword>Nucleotidyltransferase activity</Keyword>
      <Ontology_ID>GO:0016779</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of ester linkages within nucleic acids.</Detail>
      <Keyword>Nuclease activity</Keyword>
      <Ontology_ID>GO:0004518</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The process in which a segment of DNA is incorporated into another, usually larger, DNA molecule such as a chromosome.</Detail>
      <Keyword>DNA integration</Keyword>
      <Ontology_ID>GO:0015074</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>FLDGIDKAQEDHDKYHSNWRAMASEFNLPPIVAKEIVASCDKCQLKGEATHGQVDCSPGIWQLDCTHLEGKIILVAVHVASGYIEAEVIPAETGQETAYFILKLAGRWPVQVIHTDNGSNFTSNTVKAACWWAGIQQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIIDIIATDIQTKELQKQIIKIQNFRVYYRDSRDPIWKGPAKLLWKGEGAVVLQDNSDIKVVPRRKVKIIKDYGKQMAGADCMASRQDED</Protein_Seq>
    <DNA_Seq>TTTTTAGATGGAATAGATAAAGCTCAAGAAGATCATGACAAATATCACAGCAATTGGAGAGCAATGGCTAGTGAGTTTAATCTGCCACCCATAGTAGCAAAAGAAATAGTAGCTAGCTGTGATAAATGTCAGCTAAAAGGGGAAGCCACACATGGACAAGTAGACTGTAGTCCAGGAATATGGCAATTAGATTGTACACATTTAGAAGGAAAAATCATCCTGGTAGCAGTCCATGTAGCCAGTGGATACATAGAAGCAGAGGTTATCCCAGCAGAAACAGGACAAGAAACAGCATACTTTATACTAAAATTAGCAGGAAGATGGCCAGTCCAAGTAATACATACAGATAATGGCAGTAATTTCACCAGTAATACAGTTAAAGCAGCCTGTTGGTGGGCAGGTATCCAACAGGAATTTGGGATTCCCTACAATCCCCAAAGTCAGGGAGTAGTAGAATCAATGAATAAAGAATTAAAGAAAATCATAGGACAGGTAAGAGATCAAGCTGAGCATCTTAAGACAGCAGTACAAATGGCAGTATTCATTCACAATTTTAAAAGAAAAGGGGGGATTGGGGGGTACAGTGCAGGGGAAAGAATAATAGACATAATAGCAACAGACATACAAACTAAAGAACTACAAAAACAAATTATAAAAATTCAAAATTTTCGGGTTTATTACAGAGACAGCAGAGATCCTATTTGGAAAGGACCAGCCAAACTACTCTGGAAAGGTGAAGGGGCAGTAGTACTACAAGATAACAGTGACATAAAGGTAGTACCAAGGAGGAAAGTAAAAATCATTAAGGACTATGGAAAACAGATGGCAGGGGCTGATTGTATGGCAAGTAGACAGGATGAAGAT</DNA_Seq>
  </Molecule_Seq>
  <Gene>
    <Gene_Name>pol</Gene_Name>
    <Genbank_ACCN>JF773855</Genbank_ACCN>
    <Protein_ACCN>AEO00311</Protein_ACCN>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Fragment-based approach to the design of ligands targeting a novel site in HIV-1 integrase</PDB_Title>
      <PDB_ID>3AO1</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AO1</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062025</ASD_Ligand>
      <PubMed_Title>Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Chemmedchem(2011)6:258-261</Journal>
      <PubMed_ID>21275048</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with [1-(4-fluorophenyl)-5-methyl-1H-pyrazol-4-yl]methanol</PDB_Title>
      <PDB_ID>3VQE</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQE</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060089</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVK</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVK</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470011</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV integrase</PDB_Title>
      <PDB_ID>3LPT</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LPT</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062005</ASD_Ligand>
      <PubMed_Title>Rational design of small molecule inhibitors of the LEDGF/75-integrase interaction and HIV replication</PubMed_Title>
      <Author>Christ F,et al.</Author>
      <Journal>Nat Chem Biol. 2010,6(6):442-448</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20473303</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 Integrase Catalytical Core Domain</PDB_Title>
      <PDB_ID>4DMN</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4DMN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062031</ASD_Ligand>
      <PubMed_Title>A multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.</PubMed_Title>
      <Author>Kessl JJ, et al.</Author>
      <Journal>J Biol Chem. 2012,287(20):16801-16811.</Journal>
      <PubMed_ID>22437836</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4-amine</PDB_Title>
      <PDB_ID>3VQQ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQQ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060091;ASD05060082</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase</PDB_Title>
      <PDB_ID>3AO4</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AO4</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062026</ASD_Ligand>
      <PubMed_Title>Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Chemmedchem(2011)6:258-261</Journal>
      <PubMed_ID>21275048</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with 4-(1H-pyrrol-1-yl)aniline</PDB_Title>
      <PDB_ID>3VQ7</PDB_ID>
      <Resolution>1.63</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQ7</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060080;ASD05060082</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase</PDB_Title>
      <PDB_ID>3AO3</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AO3</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060095</ASD_Ligand>
      <PubMed_Title>Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Chemmedchem(2011)6:258-261</Journal>
      <PubMed_ID>21275048</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV integrase</PDB_Title>
      <PDB_ID>3LPU</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LPU</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470001</ASD_Ligand>
      <PubMed_Title>Rational design of small molecule inhibitors of the LEDGF/75-integrase interaction and HIV replication</PubMed_Title>
      <Author>Christ F,et al.</Author>
      <Journal>Nat Chem Biol. 2010,6(6):442-448</Journal>
      <PubMed_ID>20473303</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HIV-1 Integrase with a non-catayltic site inhibitor</PDB_Title>
      <PDB_ID>4E1M</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4E1M</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05068001</ASD_Ligand>
      <PubMed_Title>New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action.</PubMed_Title>
      <Author>Tsiang, M., et al.</Author>
      <Journal>J.Biol.Chem.(2012)287:21189-21203</Journal>
      <PubMed_ID>22535962</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVH</PDB_ID>
      <Resolution>1.88</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVH</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470002</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with N-METHYL-1-(4-METHYL-2-PHENYL-1,3-THIAZOL-5-YL)METHANAMINE</PDB_Title>
      <PDB_ID>3VQ5</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQ5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060079</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVC</PDB_ID>
      <Resolution>1.77</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470006</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVA</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470004</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase</PDB_Title>
      <PDB_ID>3AO5</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AO5</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062030</ASD_Ligand>
      <PubMed_Title>Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Chemmedchem(2011)6:258-261</Journal>
      <PubMed_ID>21275048</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with (5-METHYL-3-PHENYL-1,2-OXAZOL-4-YL)METHANOL</PDB_Title>
      <PDB_ID>3VQC</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQC</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060087</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVF</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVF</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470007</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVN</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470014</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AV9</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AV9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470003</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HIV-1 INTEGRASE: SIMILARITY TO OTHER POLYNUCLEOTIDYL TRANSFERASES</PDB_Title>
      <PDB_ID>1ITG</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ITG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.</PubMed_Title>
      <Author>Dyda, F., et al.</Author>
      <Journal>Science(1994)266:1981-1986</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/7801124?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of HIV-1 Integrase with a non-catayltic site inhibitor</PDB_Title>
      <PDB_ID>4E1N</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4E1N</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05068002</ASD_Ligand>
      <PubMed_Title>New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action.</PubMed_Title>
      <Author>Tsiang, M., et al.</Author>
      <Journal>J.Biol.Chem.(2012)287:21189-21203</Journal>
      <PubMed_ID>22535962</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with 2,3-dihydro-1,4-benzodioxin-5-ylmethanol</PDB_Title>
      <PDB_ID>3VQP</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQP</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060090</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVI</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVI</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470009</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with 1-benzothiophen-6-amine 1,1-dioxide</PDB_Title>
      <PDB_ID>3VQA</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQA</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060084;ASD05060082</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVG</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVG</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470008</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of HIV-1 integrase core domain in complex with sucrose</PDB_Title>
      <PDB_ID>3L3V</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3L3V</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060082</ASD_Ligand>
      <PubMed_Title>Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Febs Lett.(2010)584:1455-1462</Journal>
      <PubMed_ID>20227411</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase</PDB_Title>
      <PDB_ID>3AO2</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AO2</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062029</ASD_Ligand>
      <PubMed_Title>Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Chemmedchem(2011)6:258-261</Journal>
      <PubMed_ID>21275048</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with 6-fluoro-4H-1,3-benzodioxine-8-carboxylic acid</PDB_Title>
      <PDB_ID>3VQB</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQB</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060086</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVM</PDB_ID>
      <Resolution>1.88</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVM</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470013</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVL</PDB_ID>
      <Resolution>1.88</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVL</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470012</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVB</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVB</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470005</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with (3R)-3,4-dihydro-2H-chromen-3-ylmethanol</PDB_Title>
      <PDB_ID>3VQ8</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQ8</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060083</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fragments bound to HIV-1 integrase</PDB_Title>
      <PDB_ID>3VQ4</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQ4</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060075</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of novel allosteric peptide inhibitors of HIV integrase in the LEDGF binding site</PDB_Title>
      <PDB_ID>3AVJ</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3AVJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03470010</ASD_Ligand>
      <PubMed_Title>Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site.</PubMed_Title>
      <Author>Rhodes DI, et al.</Author>
      <Journal>Chembiochem. 2011,12(15):2311-2315</Journal>
      <PubMed_ID>21850718</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase</PDB_Title>
      <PDB_ID>3OVN</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3OVN</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05062028</ASD_Ligand>
      <PubMed_Title>Fragment-based design of ligands targeting a novel site on the integrase enzyme of human immunodeficiency virus 1</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>Chemmedchem(2011)6:258-261</Journal>
      <PubMed_ID>21275048</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIV-1 IN core domain in complex with 5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid</PDB_Title>
      <PDB_ID>3VQD</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_Method>X-ray</PDB_Method>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3VQD</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD05060088</ASD_Ligand>
      <PubMed_Title>Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?</PubMed_Title>
      <Author>Wielens, J., et al.</Author>
      <Journal>J Biomol Screen(2013)18:147-159</Journal>
      <PubMed_ID>23139382</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.hh.d.c.c.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1itg</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,98,Ala;site,102,Leu;site,125,Thr;site,128,Ala;site,129,Ala</Site_Detail>
      <Site_Reference>Kessl JJ, et al. J Biol Chem. 2012,287(20):16801-16811.;Selwood T, et al. Arch Biochem Biophys. 2012,519(2):131-143.;Jaffe EK. Curr Top Med Chem. 2013,13(1):55-63.</Site_Reference>
      <Site_Type>Morpheein model</Site_Type>
      <PDB_ID>3LPU;3LPT;3AVI;3AVN;3AVM;3AVL;3AVK;3AVJ;3AVH;3AVG;3AVF;3AVC;3AVB;3AVA;3AV9;3AO2;3AO5;3AO4;3AO3;3AO1;3OVN;4DMN</PDB_ID>
      <PubMed_ID>22437836;22182754;23409765</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00390001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060057</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060059</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060060</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060062</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060063</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060064</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060065</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060066</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060067</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060068</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060069</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060070</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060071</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060072</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060073</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060074</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060075</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060076</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060077</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060079</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060080</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060082</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060083</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060084</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060086</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060087</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060088</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060089</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060090</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060091</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05060095</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05062031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05068001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05068002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>